In conclusion, quercetin at 15μM in vitro and 15 mg/kg BW in vivo, inhibits Akt/mTOR signaling, induces cell cycle arrest, and inhibits BC cell and tumor growth, and appears to be the most active ingredient in the RQC formulation. This evidence concerns the gene AKT1 and neoplasm.